April is Testicular Cancer Awareness month!
Neuroendocrine Cancer of the Testes accounts for less than 1% of all testicular tumours and can be divided into 3 subtypes:
- Primary Testicular Neuroendocrine Cancer (approximately 76%)
- Secondary Neuroendocrine Cancer of the Testes (approximately 6%)
- Those associated with testicular teratoma*.
*Subtype 3 should be considered separately to 1 and 2, as care and outcome is different – being more similar to those of testicular teratoma (a germ-cell type of testicular cancer).
Germ cell tumours are by far the most common testicular tumours.
Find out more about Neuroendocrine of the Testes here – https://www.neuroendocrinecancer.org.uk/cells-system/testicles/